OTCBX
Price
$24.47
Change
+$0.12 (+0.49%)
Updated
Nov 13 closing price
PMAQX
Price
$48.46
Change
+$0.16 (+0.33%)
Updated
Nov 13 closing price
Ad is loading...

OTCBX vs PMAQX

Header iconOTCBX vs PMAQX Comparison
Open Charts OTCBX vs PMAQXBanner chart's image
MFS Mid Cap Growth B
Price$24.47
Change+$0.12 (+0.49%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$48.46
Change+$0.16 (+0.33%)
VolumeN/A
CapitalizationN/A
OTCBX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OTCBX vs. PMAQX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTCBX is a StrongBuy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.8B vs. OTCBX (15.7B). PMAQX pays higher dividends than OTCBX: PMAQX (0.10) vs OTCBX (0.00). OTCBX was incepted earlier than PMAQX: OTCBX (31 years) vs PMAQX (8 years). OTCBX is a more actively managed with annual turnover of: 30.00 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than OTCBX: PMAQX (0) vs OTCBX (1000). PMAQX annual gain was more profitable for investors over the last year : 32.12 vs. OTCBX (25.32). PMAQX return over 5 years is better than : 55.10 vs. OTCBX (45.11).
OTCBXPMAQXOTCBX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years8 years-
Gain YTD16.89926.39564%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets15.7B29.8B53%
Annual Yield % from dividends0.000.10-
Returns for 1 year25.3232.1279%
Returns for 3 years-6.426.88-93%
Returns for 5 years45.1155.1082%
Returns for 10 years87.89N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics